Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

This publication has 22 references indexed in Scilit:

• Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed
  Atherosclerosis, 2003
• Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 ( TIMP-1 ) Gene
  Circulation Research, 2002
• Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis
  Circulation Research, 2002
• Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease
  Circulation, 2001
• Tissue inhibitors of metalloproteinases: evolution, structure and function
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
• Tissue inhibitors of metalloproteases: Regulation and biological activities
  Clinical & Experimental Metastasis, 2000
• Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic Lesions
  Circulation, 1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
  Circulation Research, 1994
• The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent.
  The Journal of cell biology, 1994